Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
19.00
-0.01 (-0.05%)
At close: Nov 20, 2024, 4:00 PM
17.99
-1.01 (-5.32%)
Pre-market: Nov 21, 2024, 4:41 AM EST
Monopar Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for MNPR stock have an average target of 27.33, with a low estimate of 10 and a high estimate of 50. The average target predicts an increase of 43.84% from the current stock price of 19.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MNPR stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $22 | Strong Buy | Maintains | $6 → $22 | +15.79% | Nov 11, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +163.16% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $6 | Strong Buy | Maintains | $2 → $6 | -68.42% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | -47.37% | May 10, 2024 |
| JonesTrading | JonesTrading | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | -47.37% | Apr 11, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.99
from -3.04
EPS Next Year
-2.53
from -1.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.89 | -1.51 | -1.28 | ||
| Avg | -1.99 | -2.53 | -4.17 | ||
| Low | -2.02 | -4.09 | -6.81 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.